Delivery of Inhaled Nitric Oxide During MRI to Ventilated Neonates and Infants

被引:1
|
作者
Carter, Bradley G. [1 ]
Swain, Rachel [1 ]
Hislop, Jaime [1 ]
Escudie, Mathilde [1 ]
Williams, Rachel H. [1 ]
机构
[1] Royal Childrens Hosp, Clin Technol Serv, Neonatal & Paediat Intens Care Units, Parkville, Vic, Australia
关键词
nitric oxide; magnetic resonance imaging; mechanical ventilators; critical care; infant; newborn child; BLOOD-FLOW;
D O I
10.4187/respcare.08408
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Many pediatric and neonatal ICU patients receive nitric oxide (NO), with some also requiring magnetic resonance imaging (MRI) scans. MRI-compatible NO delivery devices are not always available. We describe and bench test a method of delivering NO during MRI using standard equipment in which a NO delivery device was positioned in the MRI control room with the NO blender component connected to oxygen and set to 80 ppm and delivering flow via 12 m of tubing to a MRI-compatible ventilator, set up inside the MRI scanner magnet room. METHODS: For our bench test, the ventilator was set up normally and connected to an infant test lung to simulate several patients of differing weight (ie, 4 kg, 10 kg, 20 kg). The NO blender delivered flows of 2-10 L/min to the ventilator to achieve a range of NO and oxygen concentrations monitored via extended tubing. The measured values were compared to calculated values. RESULTS: A range of NO concentrations (12-41 ppm) and F-IO2 values (0.67-0.97) were achieved during the bench testing. The additional flow increased delivered peak inspiratory pressure and PEEP by 1-5 cm H2O. Calculated values were within acceptable ranges and were used to create a lookup table. CONCLUSIONS: In clinical use, this system can safely generate a range of NO flows of 15-42 ppm with an accompanying F-IO2 range of 0.34-0.98. (C) 2021 Daedalus Enterprises.
引用
收藏
页码:1254 / 1262
页数:9
相关论文
共 50 条
  • [21] Inhaled nitric oxide delivery systems
    Troncy, E
    Francoeur, M
    Blaise, G
    ANESTHESIOLOGY, 1997, 87 (06) : 1591 - 1592
  • [22] Inhaled nitric oxide delivery and monitoring
    Montgomery, FJ
    Berssenbrugge, AD
    JOURNAL OF CLINICAL MONITORING AND COMPUTING, 1999, 15 (05) : 325 - 335
  • [23] Inhaled nitric oxide: Current and future uses in neonates
    Kinsella, JP
    Abman, SH
    SEMINARS IN PERINATOLOGY, 2000, 24 (06) : 387 - 395
  • [24] Indomethacin and inhaled nitric oxide and platelet function in neonates
    Cheung, PY
    Peliowski, A
    Radomski, MW
    BIOLOGY OF NITRIC OXIDE, PT 7, 2000, 16 : 100 - 100
  • [25] Response to Inhaled Nitric Oxide in Premature and Term Neonates
    Thomas Hoehn
    Martin F. Krause
    Drugs, 2001, 61 : 27 - 39
  • [26] Response to inhaled nitric oxide in premature and term neonates
    Hoehn, T
    Krause, MF
    DRUGS, 2001, 61 (01) : 27 - 39
  • [27] SAFETY OF INHALED NITRIC-OXIDE IN PREMATURE NEONATES
    AHLUWALIA, JS
    KELSALL, AWR
    RAINE, J
    RENNIE, JM
    MAHMOOD, M
    ODURO, A
    LATIMER, R
    PICKETT, J
    HIGENBOTTAM, TW
    ACTA PAEDIATRICA, 1994, 83 (03) : 347 - 348
  • [28] Inhaled nitric oxide in neonates with persistent pulmonary hypertension
    Tworetzky, W
    Bristow, J
    Moore, P
    Brook, MM
    Segal, MR
    Brasch, RC
    Hawgood, S
    Fineman, JR
    LANCET, 2001, 357 (9250): : 118 - 120
  • [29] Evaluation of nitrogen dioxide scavengers during delivery of inhaled nitric oxide
    Lindberg, L
    Rydgren, G
    BRITISH JOURNAL OF ANAESTHESIA, 1998, 81 (03) : 404 - 408
  • [30] Inhaled nitric oxide for preterm infants - Reply
    Barrington, Keith J.
    Finer, Neil N.
    PEDIATRICS, 2008, 121 (06) : 1288 - +